Affiliations: [a] Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA | [b] CEINGE biotecnologie avanzate, Dipartimento di Biochimica e Biotecnologie Mediche, Università di Napoli Federico II, Naples, Italy | [c] Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA
Correspondence:
[*]
Corresponding author: Dr. Luciano D'Adamio, Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA. Tel.: +1 718 430 3245; Fax: +1 718 430 8711; E-mail: [email protected].
Abstract: The phosphorylation of Tyr-682 residue in the intracellular domain (AID) of amyloid-β protein precursor (AβPP) is significantly enhanced in Alzheimer's disease patients' brain. The role of this phosphotyrosine, however, remains elusive. Here we report that phosphorylation of Tyr-682 inhibits the interactions between AβPP and Fe65, which is the main regulatory mechanism controlling Fe65 nuclear signaling. Furthermore, we show that tyrosine phosphorylation of AβPP also inhibits interaction of the two other Fe65 family members, Fe65L1 and Fe65L2. Likewise, docking of Fe65, Fe65L1 and Fe65L2 to APLP1 and APLP2, the two other members of the AβPP-gene family, is abolished by analogous phosphorylation events. Our results indicate that phosphorylation of the cytoplasmic tail of AβPP on Tyr-682 represents a second mechanism, alternative to AβPP processing by secretases, that regulates AβPP/Fe65 downstream signaling pathways.
Keywords: Amyloid-β protein precursor, Fe65, phosphorylation, threonine, tyrosine
